Open AccessPharmacokinetics, Safety, and Efficacy of Gadopiclenol in Pediatric Patients Aged 2 to 17 Years
Author(s) -
Elżbieta Jurkiewicz,
Silvia Tsvetkova,
Анна Гринберг,
Blaise Pasquiers
Publication year - 2022
Publication title -
investigative radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.33
H-Index - 114
eISSN - 1536-0210
pISSN - 0020-9996
DOI - 10.1097/rli.0000000000000865
Subject(s) - cohort , medicine , pharmacokinetics , population , adverse effect , pediatrics , cohort study , environmental health
The aim of this study was to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of gadopiclenol, a new high-relaxivity gadolinium-based contrast agent, in children aged 2 to 17 years.